224 related articles for article (PubMed ID: 18160590)
1. Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
Sucker C; Sabel M; Stummer W; Zotz RB; Scharf RE; Gerhardt A
Clin Appl Thromb Hemost; 2008 Oct; 14(4):472-5. PubMed ID: 18160590
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant factor VIIa in the perioperative period.
Levi M
Hamostaseologie; 2009 Jan; 29(1):68-70. PubMed ID: 19151850
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative use of recombinant activated factor VII (rFVIIa).
De Gasperi A
Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII prevents bleeding during a surgical procedure in a patient with uncontrollable rectal hemorrhage.
Sánchez MP; Nebreda JB; García VC
Am J Gastroenterol; 2002 May; 97(5):1266-7. PubMed ID: 12014744
[No Abstract] [Full Text] [Related]
6. [Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports].
Moravcsik B; Nemes L; Zsiros L
Orv Hetil; 2008 Aug; 149(33):1565-8. PubMed ID: 18687576
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII: current perspectives and Epworth experience.
Labattaglia MP; Ihle B
Heart Lung Circ; 2007; 16 Suppl 3():S96-101. PubMed ID: 17627885
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect.
Dempfle CE; Frietsch T; Hoffmann T; Ahmad-Nejad P; Neumaier M; Borggrefe M
Haemophilia; 2008 Sep; 14(5):1147-9. PubMed ID: 18582229
[No Abstract] [Full Text] [Related]
9. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
Hartmann M; Sucker C; Messing M
J Neurosurg; 2006 Jan; 104(1 Suppl):55-8. PubMed ID: 16509483
[TBL] [Abstract][Full Text] [Related]
10. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
Wahlgren CM; Swedenborg J
Eur J Vasc Endovasc Surg; 2003 Aug; 26(2):221-2. PubMed ID: 12917843
[TBL] [Abstract][Full Text] [Related]
11. Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review.
Huang C; Yu Y; Zhai N; Mo W; Lin F
Medicine (Baltimore); 2023 Dec; 102(52):e36694. PubMed ID: 38206717
[TBL] [Abstract][Full Text] [Related]
12. Management of gynecologic surgery in the patient with factor XI deficiency: a review of the literature.
Steward RG; Saleh OA; James AH; Shah AA; Price TM
Obstet Gynecol Surv; 2012 May; 67(5):291-7. PubMed ID: 22624777
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients.
Hardy JF; Bélisle S; Van der Linden P
Curr Opin Anaesthesiol; 2009 Feb; 22(1):95-9. PubMed ID: 19295298
[TBL] [Abstract][Full Text] [Related]
14. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
White B; O'Connor H; Smith OP
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):155-7. PubMed ID: 10759008
[TBL] [Abstract][Full Text] [Related]
15. [Uncontrollable bleeding in a patient with head trauma treated with blood component therapy guided by thromboelastography].
Hansen MK; Jensen MK; Andersen C
Ugeskr Laeger; 2006 Oct; 168(41):3535-6. PubMed ID: 17059810
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant activated factor VII (Novoseven) in trauma and surgery: analysis of outcomes reported to an international registry.
Grounds RM; Seebach C; Knothe C; Paluszkiewicz P; Smith TS; Kasal E; Lecumberri R; Urbanec R; Haas T; Wujtewicz M; Rehorkova D; Pelichovska M; Lange M; Uranga M; Bosman R; Rommes JH; Koscielny J
J Intensive Care Med; 2006; 21(1):27-39. PubMed ID: 16698742
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.
Mathijssen NC; Masereeuw R; Verbeek K; Lavergne JM; Costa JM; van Heerde WL; Nováková IR
Br J Haematol; 2004 May; 125(4):494-9. PubMed ID: 15142120
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
